2015. ISPOR European Congress – Using an Economic Model to Choose Initial Appropriate Antibiotic Therapy Based on Differences in In-Vitro Susceptibility to Ceftolozane/ Tazobactam and Piperacillin/Tazobactam

Prabhu V, Sen S, Miller B, Basu A, Medic G. Using an Economic Model to Choose Initial Appropriate Antibiotic Therapy Based on Differences in In-Vitro Susceptibility to Ceftolozane/ Tazobactam and Piperacillin/Tazobactam. Value Health 2015 Nov;18(7):A536. Presented at: ISPOR 18th Annual European Congress; November 10, 2015; Milan, Italy.